We have recently described an insulin-resistant patient with leprechaunism (leprechaun G.) having a homozygous leucine + proline mutation at amino acid position 233 in the a-chain of the insulin receptor. The mutation results in a loss of insulin binding to cultured fibroblasts. Fibroblasts from the patient and control individuals were used to quantify the stimulation of 2-deoxyglucose uptake by insulin and insulin-like growth factor 1 (IGF-1). Insulin hardly stimulates basal 2-deoxyglucose uptake in the patient's fibroblasts whereas in control fibroblasts the uptake of 2-deoxyglucose is stimulated by insulin approximately 1.7 times. In contrast, IGF-1 stimulates hexose uptake in the patient's fibroblasts 1.8 times, a similar value to that obtained by stimulation of control fibroblasts with insulin or IGF-1. With both types of fibroblasts, maximal IGF-1 response is reached at about 10 nM IGF-1, the EDso being approximately 4 nM.The results indicate that the insulin responsive glucose transport in primary fibroblasts is functionally linked to the receptor for IGF-1. Insulin binds with an approximately 200-fold lower affinity to IGF-1 receptors, compared to homologous IGF-1 binding. As an insulin concentration of 10 pM is unable to give maximal stimulation of glucose uptake in the patient's fibroblasts, which is already seen with 10 nM IGF-1, it seems that occupation of IGF-1 receptors by insulin on the patient's cells is less efficient at stimulating hexose uptake compared to homologous activation.The receptors for insulin and insulin-like growth factor 1 (IGF-1) are both membrane proteins of clzPz subunit composition. The a-chain is located extracellularly and binds the hormone whereas the P-chain traverses the plasma membrane [I -31. Ligand binding to the a-chain induces in the cytoplasmic part of the P-chain a tyrosine kinase activity, resulting in receptor autophosphorylation followed by an enhanced tyrosine kinase activity towards external SUbStrdteS [4]. This process is assumed to be the first step in the signalling pathway [5]. Both receptors show a high degree of sequence similarity.Insulin induces in cells a variety of metabolic effects, like stimulation of glucose uptake and a mitogenic response. IGF-1 induces in cells responses which are similar to those seen with insulin, though the biological function of IGF-1 seems to be more as a mitogen [6]. Insulin and IGF-1 show a certain degree of cross-binding to their repective heterologous receptors, e.g. insulin has an ~2 0 0 fold lower affinity to IGF-1 receptors than IGF-1. As most cells have both receptors, the cross-binding makes it difficult to distinguish whether a particular response proceeds via the homologous or heterologous receptor. By the use of transfected cell lines expressing high levels of receptors for IGF-1, it has been shown that glucose transport can be activated via the IGF-1 receptor [7,8]. Whether this coupling also exists at physiological expression levels of the receptor is unclear as it has recently been shown that in human adipocy...